Referred Tests
Access across
the world
Evidence-based testing for the detection and identification of infectious diseases
Mayo Clinic’s internationally renowned clinical microbiology laboratories span all areas of conventional and molecular medical microbiology, offering a broad selection of tests designed for rapid identification and in-depth characterization of the causative agents of infectious diseases.
Our laboratories have developed and implemented culture techniques, immunoassays, antimicrobial susceptibility testing, and molecular methods for rapid detection, identification, and characterization, as well as provision treatment guidance for microbial pathogens.
Results that matter
We're dedicated to our patients' health and well-being,
and proud of the outstanding outcomes we achieve.
3 million
tests performed annually
70
years of diagnosing and treating infectious diseases
7
specialized laboratories performing
infectious disease testing
24/7
support from Mayo Clinic physicians and scientists
Physician-led subspecialized laboratories
Our laboratories are managed by physicians and scientists with expert knowledge regarding the clinical implications of each test result and how it can impact patient care.
The right tests, not the most tests
Our clinicians and laboratorians focus on maintaining high-quality, cost-effective, and efficient care by using algorithmic, evidence-based approaches that lead to correct diagnoses and treatment while minimizing unnecessary testing.
Access across
the globe
Every laboratory offers testing. But at Mayo Clinic Laboratories, in addition to our comprehensive testing menu, we offer a service that allow patients access to Mayo Clinic experts from across the world.
COVID-19 Resource Center
We are rapidly expanding our COVID-19 testing to provide accurate information for health care professionals on the front lines of this crisis. We will continue coordinating closely with state and federal officials to offer testing in the areas with the greatest need.
The Latest
Thank you to our staff at Mayo Clinic who step up daily during this time of need to provide access to testing during the global pandemic. We appreciate each one of you and all the sacrifices you personally have made throughout this past year.
A small but in-depth study conducted a postmortem evaluation of the heart tissue of 15 patients with COVID-19, including the first postmortem cardiac findings of three patients who had cleared the virus.
Joshua Bornhorst, Ph.D., associate director of Mayo Clinic's Clinical Immunoassay Lab, explains how humans can develop an allergy to the alpha-gal molecule, and he describes a new allergen antibody test that can be used to detect it. Dr. Bornhorst also reviews other tests that should be used in conjunction with alpha-gal testing to accurately identify the scope and underlying cause of the allergy.
Nancy Wengenack, Ph.D. gives an overview of this test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing compares to other testing approaches, and what clinical action can be taken due to the results of this testing.
PACE
This “Specialty Testing” webinar will serve as a live virtual town hall for Mayo Clinic Laboratories clients, and will cover the latest in COVID-19 testing. This event will feature experts who were directly involved in the development of Mayo Clinic's molecular, antibody, and antigen testing. They will address the current state of testing and answer audience questions.